2nd Annual Evidence 360 Summit USA Edition

Best Real World Evidence conference in USA in 2026

2nd Annual EVIDENCE 360: RWE, Pricing and Market Acess Summit: USA Edition

📍 Hilton Garden Inn Camden Waterfront Philadelphia

đź“… 08-09 June 2026

Days
Hours
Minutes
Seconds

Best Real World Evidence conference in USA in 2026

2nd Annual EVIDENCE 360: RWE Pricing and Market Acess Summit USA Edition

📍 Philadelphia, USA
đź“… 08-09 June 2026

Days
Hours
Minutes
Seconds

Event Overview

Our 2nd Annual EVIDENCE 360 Summit USA serves as a premier platform for U.S. healthcare stakeholders to examine the evolving role of Real-World Evidence (RWE) in shaping market access, pricing, and reimbursement strategies. As the demand grows for more cost-effective, outcomes-driven healthcare, EVIDENCE 360 USA brings together leading voices from pharma, biotech, payers, regulators, HTA bodies, and digital health innovators to address the most urgent access and value challenges across the U.S. market.

As the US market enters a new era defined by IRA drug price negotiations, increased CMS scrutiny, value-based care expansion, AI-enabled evidence generation, and growing demands for equity-driven outcomes, EVIDENCE 360 USA 2026 will focus on how companies can generate, translate, and operationalize RWE that truly moves payer and policy decisions.

This senior-level, two-day summit brings together pharma, biotech, payers, regulators, market access and HEOR leaders, RWE experts, and data innovators to explore how real-world evidence is actively reshaping pricing, reimbursement, and access decisions in the evolving US healthcare system.

Join peers and experts to explore how RWE is transforming evidence generation, payer engagement, and regulatory strategy—empowering better, faster, and smarter healthcare decisions.

Where Data Drives Access & Decisions

Attendees
0 +
Senior Decision Makers
0 +
Speakers
0 +
Sponsors
0 +

Explore the Key Highlights

The evolving role of RWE in U.S. market access and reimbursement

Payer expectations for evidence, value, and outcomes

Real-world data integration into HEOR and regulatory strategy

Leveraging digital tools, AI, and decentralized data sources

Case studies on successful RWE-driven access pathways

Who Should Attend

Healthcare Professionals in

Real World Evidence

Market Access

Value Access

HEOR

Pricing & Reimbursement

Epidemiology

HTA

Patient Advocacy

Regulatory

Payers/Policy

Digital Health

Data Platforms

Consulting

Investors

Others

Final Decision Makers

Chief Executive Officer

Chief Scientific Officer

President

Vice President

Executive Director

Assoicate/Senior Director

Manager/Sr. Manager

Head of Department

Why Attend

Benchmark how ICER and U.S. payers are using RWE in value assessments

Gain clarity on FDA’s expectations for RWE in regulatory submissions

Learn how to build fit-for-purpose RWD strategies across therapeutic areas

Hear case studies on RWE-backed label expansions and reimbursement wins

Network with access, HEOR, and regulatory leaders shaping U.S. evidence strategy

Evidence 360 Summit USA Speakers

From RWE Trailblazers to Access Strategy Leaders

Join a distinguished lineup of RWE experts, HEOR leaders, market access strategists, and regulatory authorities shaping the future of evidence-driven healthcare in the U.S. The 2nd Annual EVIDENCE 360 USA will bring together influential voices from biopharma, payers, HTA bodies, regulatory agencies, and data science—covering the full spectrum of real-world evidence generation, regulatory-grade data strategy, and value-based access in a shifting U.S. healthcare landscape.

Speakers 2026

Charles Makin

Charles Makin

Head, RWE US, Boehringer Ingelheim

Sunil Dravida

Sunil Dravida

Global Head, Real World Data, Takeda

Jennifer Webster

Jennifer Webster

VP, RWE Platforms & Partnerships, Pfizer

Yash Jalundhwala

Yash Jalundhwala

Senior Director, Global Market Access & Pricing, Moderna

Kunal Kaushal

Kunal Kaushal

Director, Analytics, Novartis

Dr. Jennifer Onwumeh-Okwundu

Dr. Jennifer Onwumeh-Okwundu

Director, Clinical Science, Pfizer

Mahek Chhatrapati

Mahek Chhatrapati

CEO, DocNexus

Shawn Du

Shawn Du

Group Director, Real World Value & Evidence, Oncology, Johnson & Johnson

Mei Yang

Mei Yang

Co-Founder, NouStarX

Rakesh Singh

Rakesh Singh

Senior Director, Value, Evidence & Outcomes, Eli Lilly

Michael Doane

Michael Doane

Senior Director, Head, HEOR, Alkermes

Rahul Khairnar

Rahul Khairnar

Director, HEOR, AbbVie

Renuka Kandikatla

Renuka Kandikatla

Health Economist, Brigham and Women's Hospital

Deb Profant

Deb Profant

Director Payer, Value & Outcomes, US Medical Affairs, Boehringer Ingelheim

Mriga Shrikhande

Mriga Shrikhande

HEOR Scientist, Cardio Diagnostics Holdings

Dusica Hadzi Boskovic

Dusica Hadzi Boskovic

Director of Global Value and Real-World Evidence, CNS and Digital Medicine, Otsuka Pharmaceuticals

Robert Kemp

Robert Kemp

President, MG Lifesciences/VP, Market Access & HEOR, Breath Therapeutics

Vishal Venkatesan

Vishal Venkatesan

Manager, Haematology Pathway Strategy, Johnson & Johnson

Becky Hollenberg

Becky Hollenberg

Senior RWD Strategy Lead, Panalgo

Lorraine Calderon

Lorraine Calderon

Associate Director, Health Economics & Market Access, Johnson & Johnson

Kavita Sail

Kavita Sail

Senior Director, Lead, Oncology Pipeline, Value and EvidenceR W E,

Radha Madhavi Ryali

Radha Madhavi Ryali

Senior Manager, RWE Analytics, Genmab

Beni Turner

Beni Turner

Senior Director, Value & Access Solutions, Magnolia Market Access

Senior Representative, MadeAI

Senior Representative, MadeAI

Agenda

Our Esteemed Sponsors & Exhibitors

Platinum Sponsor

Silver Sponsor

Bronze Sponsors

Exhibitor

Media Partners

LISTING PARTNERS​

Past Edition Sponsors

Why Sponsor?

Dedicated Prime Speaking Slot

Exhibition Opportunity

One-to-One Meetings

Pre-Qualified Leads

High-Level Networking

Brand Impact

View The Glimpses Of Our Past Edition

View the Glimpses of Our Past Edition

EVIDENCE 360 Summit 2025 – Philadelphia

The inaugural EVIDENCE 360 Summit was held on June 26–27, 2025, at Hotel Kimpton Palomar, Philadelphia, bringing together leaders from the pharmaceutical, biotech, payer, and regulatory sectors.

Over two engaging days, the summit featured insightful keynotes, real-world case studies, and thought-provoking panel debates on how real-world evidence is reshaping pricing, reimbursement, and market access strategies.

The U.S. edition firmly established EVIDENCE 360 as a premier platform for advancing RWE-driven access, offering unmatched opportunities to exchange ideas, build partnerships, and explore innovative solutions that are shaping the future of healthcare decision-making.

Evidence 360 USA Edition

Elevate your brand where crypto’s most influential minds connect beyond the conference floor.

Venue

Hilton Garden Inn Camden Waterfront Philadelphia,

Address: 1 Penn St, Camden, NJ 08102, United States

Venue Gallery

Contact Our Team Today

For Speaking &
Partnerships
Nikita Patankar Parab
Founder, Managing Director
For Sponsorship & Delegation
Prativa Sinha
Director

2nd Annual EVIDENCE 360 Summit: USA Edition Download Agenda